0001213900-14-000812.txt : 20140212 0001213900-14-000812.hdr.sgml : 20140212 20140212171136 ACCESSION NUMBER: 0001213900-14-000812 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20140212 DATE AS OF CHANGE: 20140212 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DARA BioSciences, Inc. CENTRAL INDEX KEY: 0000919745 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043216862 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-48323 FILM NUMBER: 14601324 BUSINESS ADDRESS: STREET 1: 8601 SIX FORKS ROAD SUITE 160 CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: (816) 914-7027 MAIL ADDRESS: STREET 1: 8601 SIX FORKS ROAD SUITE 160 CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: DARA BIOSCIENCES INC DATE OF NAME CHANGE: 20080211 FORMER COMPANY: FORMER CONFORMED NAME: POINT THERAPEUTICS INC DATE OF NAME CHANGE: 20020328 FORMER COMPANY: FORMER CONFORMED NAME: HMSR INC DATE OF NAME CHANGE: 20010618 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ALPHA CAPITAL ANSTALT CENTRAL INDEX KEY: 0001140358 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: PRADAFAUT 7 STREET 2: FURSTENTUMS 1490 CITY: VADUZ LIECHTENSTEIN STATE: C4 ZIP: 99999 BUSINESS PHONE: 0114232376363 MAIL ADDRESS: STREET 1: PRADAFAUT 7 STREET 2: FURSTENTUMS 1490 CITY: VADUZ LIECHTENSTEIN STATE: C4 ZIP: 99999 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA CAPITAL AKTIENGESELLSCHAFT DATE OF NAME CHANGE: 20010510 SC 13G/A 1 sc13ga10214alpha_darabio.htm AMENDMENT NO. 1 TO SCHEDULE 13G sc13ga10214alpha_darabio.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1)
 
DARA BIOSCIENCES, INC.
(Name of Issuer)
 
 
COMMON STOCK
(Title of Class of Securities)
 
 
23703P106
(CUSIP Number)

 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Raule 13d-1(c)
 
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
(Continued on following page(s)

Page 1 of 4 Pages
 
 
 
 
 
CUSIP No. 23703P106
13G
Page 2 of 4 Pages
 
1.
NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
   Alpha Capital Anstalt
 
2.
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP:
  (a)    o
  (b)    o
 
3.
SEC USE ONLY
 
4.
CITIZENSHIP OR PLACE OF ORGANIZATION
   Liechtenstein
 
5.
SOLE VOTING POWER, NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON – 6,214,731 Common Stock
 
6.
SHARED VOTING POWER - None
 
7.
SOLE DISPOSITIVE POWER – 6,214,731 shares of Common Stock
 
8.
SHARED DISPOSITIVE POWER – None 
 
9.
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON - 6,214,731 shares of Common Stock
 
10.
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES     x
 
11.
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
   7.69%
 
12.
TYPE OF REPORTING PERSON
   CO
 
 
 
 
 

CUSIP No. 23703P106
13G
Page 3 of 4 Pages

ITEM 1 (a) NAME OF ISSUER: DARA BioSciences, Inc.

ITEM 1 (b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:

              8601 Six Forks Road, Suite 160, Raleigh, North Carolina 27615

ITEM 2 (a) NAME OF PERSON FILING: Alpha Capital Anstalt

ITEM 2 (b) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:

  Pradafant 7, Furstentums 9490, Vaduz, Liechtenstein

ITEM 2 (c) CITIZENSHIP: Liechtenstein

ITEM 2 (d) TITLE OF CLASS OF SECURITIES: Common Stock

ITEM 2 (e) CUSIP NUMBER: 23703P106

ITEM 3 IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B) OR 13D-2(B):  Not applicable

ITEM 4 OWNERSHIP
 
  (a) AMOUNT BENEFICIALLY OWNED: 6,214,731 Shares of Common Stock
 
  (b) PERCENT OF CLASS: 7.69%
 
  (c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
 
           (i)   SOLE POWER TO VOTE OR DIRECT THE VOTE

6,214,731 Shares

           (ii)  SHARED POWER TO VOTE OR DIRECT THE VOTE

0 Shares

           (iii) SOLE POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF
 
6,214,731 Shares

           (iv) SHARED POWER TO DISPOSE OR TO DIRECT THE DISPOSITION OF

0 Shares

 
 
 

CUSIP No. 23703P106
13G
Page 4 of 4 Pages
 
ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

Not applicable
 
ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

Not applicable

ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

Not applicable

ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF A GROUP

Not applicable

ITEM 9   NOTICE OF DISSOLUTION OF GROUP

Not applicable
 
SIGNATURE

         After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 
February 12, 2014
 
(Date)
   
 
/s/ Konrad Ackermann
 
(Signature)
   
 
Konrad Ackermann, Director
 
(Name/Title)